[细胞黄素治疗倦怠综合征的疗效]
[The efficacy of cytoflavin in the treatment of burnout syndrome].
作者信息
Chutko L S, Surushkina S Yu, Yakovenko E A, Rozhkova A V, Anisimova T I, Bondarchuk Yu L
机构信息
Bekhterev Institute of Human Brain, Russian Academy of Sciences, St. Petersburg.
出版信息
Zh Nevrol Psikhiatr Im S S Korsakova. 2015;115(10):66-70. doi: 10.17116/jnevro201511510166-70.
OBJECTIVE
To evaluate the efficacy of cytoflavin in the treatment of patients with burnout syndrome.
MATERIAL AND METHODS
Authors performed clinical, psychological and neurophysiological examinations of 60 patients, aged 34-43 years. Results of pharmacological therapy with cytoflavin (30 patients) or ethylmethylhydroxypyridine succinate (30 patients) were compared. Control examination was conducted immediately after treatment and then after 30 days to assess the stability of the resulting effect.
RESULTS AND CONCLUSION
The higher efficacy of cytoflavin (improvement in 80% of cases) as compared to ethylmethylhydroxypyridine succinate (improvement in 70% of cases) was identified. After cytoflavin treatment, the improvement was more persistent. These clinical results are confirmed by the results of psychological and neurophysiological research.
目的
评估细胞黄素治疗倦怠综合征患者的疗效。
材料与方法
作者对60名年龄在34至43岁之间的患者进行了临床、心理和神经生理学检查。比较了细胞黄素（30例患者）或琥珀酸乙甲基羟基吡啶（30例患者）的药物治疗结果。治疗后立即进行对照检查，然后在30天后进行对照检查，以评估所产生效果的稳定性。
结果与结论
确定细胞黄素（80%的病例有改善）比琥珀酸乙甲基羟基吡啶（70%的病例有改善）具有更高的疗效。细胞黄素治疗后，改善效果更持久。这些临床结果得到了心理和神经生理学研究结果的证实。
Zotero 插件